Compare TransMedics Group Inc (TMDX) vs Valero Energy Corporation (VLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TransMedics Group Inc vs Valero Energy Corporation — how do they compare? TransMedics Group Inc trades at $86.5 (market cap $3.00B), while Valero Energy Corporation trades at $392.04 (market cap $111.99B). The key difference: Valero Energy Corporation is far larger — about 37.3× TransMedics Group Inc's market cap, and Valero Energy Corporation pays a 1.23% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| TMDX | VLO | |
|---|---|---|
Market Cap | $3.00B | $111.99B |
Sector | Technology | Energy |
52-Week High | $150.42 | $388.95 |
52-Week Low | $61.99 | $156.39 |
Enterprise Value | $3.39B | $115.46B |
Dividend Yield | — | 1.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TransMedics Group (TMDX) trades at $88.27, down 1.9% on the day, with a bullish technical signal from moving averages but mixed earnings performance. The company reported strong 2025 results with $605M revenue and 31.4% net margin, though 2026 projections show margin compression. Recent news highlights growth initiatives in kidney transplantation and European markets, alongside ongoing legal investigations into fiduciary duties.
The stock offers upside to the $99.57 consensus price target, supported by analyst bullishness (69% buy ratings), but faces risks from margin pressure, legal scrutiny, and earnings misses. Revenue growth remains a key catalyst, though execution risks and investor sentiment headwinds warrant caution.
Valero Energy (VLO) trades at $382.85, up 3.27% with strong technical momentum and bullish moving averages. The stock shows robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and attractive valuation ratios (P/E 15.97, P/S 0.83). Recent news highlights inclusion in growth stock lists and upcoming Q3 2026 earnings on October 22, 2026.
Outlook remains positive with favorable refining conditions and analyst consensus at Buy (58%). Key risks include revenue decline from $176.4B (2022) to $122.7B (2025) and political pressure on gas prices. The stock offers value but faces sector volatility and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
